Search

Search Constraints

You searched for: Author/Creator Badalamenti, Giuseppe

Search Results

1. Activity and safety of temozolomide in advanced adrenocortical carcinoma patients. Issue 6 (December 2019)

3. Baseline plasma levels of soluble PD-1, PD-L1, and BTN3A1 predict response to nivolumab treatment in patients with metastatic renal cell carcinoma: a step toward a biomarker for therapeutic decisions. (1st January 2020)

4. BRCA1/2 pathogenic variants in triple-negative versus luminal-like breast cancers: genotype–phenotype correlation in a cohort of 531 patients. (December 2020)

5. Can the plasma PD-1 levels predict the presence and efficiency of tumor-infiltrating lymphocytes in patients with metastatic melanoma?. (May 2019)

6. Challenges and advances for the treatment of renal cancer patients with brain metastases: From immunological background to upcoming clinical evidence on immune-checkpoint inhibitors. (July 2021)

7. Clinical Impact of Cystatin C/Cathepsin L and Follistatin/Activin A Systems in Breast Cancer Progression: A Preliminary Report. (20th October 2016)

8. Dedifferentiated retroperitoneal large liposarcoma and laparoscopic treatment: Is it possible and safe? The first literature case report. (2019)

9. Detection of RAS mutations in circulating tumor DNA: a new weapon in an old war against colorectal cancer. A systematic review of literature and meta-analysis. (September 2019)

10. Ductal lavage: a way of carefully tracing the breast-secreting duct. Issue 3 (May 2006)